Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies.
Laham Y, Ringelstein-Harlev S, Kurnik D, Fineman R, Yehudai-Ofir D, Bonstein L, Setter-Marco N, Braun E, Ghersin I, Zuckerman T, Beyar-Katz O. Laham Y, et al. Among authors: ringelstein harlev s. Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2024.286714. Online ahead of print. Haematologica. 2025. PMID: 39781629 Free article.
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumab.
Fadaos N, Dor YB, Azoulay T, Leiba R, Sharon-Horesh N, Levi T, Horowitz NA, Tzoran I, Lavi N, Beyar-Katz O, Dann EJ, Zuckerman T, Ringelstein-Harlev S. Fadaos N, et al. Among authors: ringelstein harlev s. Ann Hematol. 2024 Dec;103(12):5861-5870. doi: 10.1007/s00277-024-06130-y. Epub 2024 Dec 12. Ann Hematol. 2024. PMID: 39663256
Eosinophilic Pleocytosis in the Cerebrospinal Fluid following CAR-T Cell Therapy for Central Nervous System Lymphoma: A Case for Warning?
Abu Ata M, Henig I, Yehudai-Ofir D, Tzoran I, Ringelstein-Harlev S, Inbar T, Slouzkey I, Karmona Fintuch M, Stern A, Stanevsky O, Weiler-Sagie M, Zohar Y, Livneh I, Merhav G, Eran A, Zuckerman T, Katz OB. Abu Ata M, et al. Among authors: ringelstein harlev s. Acta Haematol. 2024 May 24:1-8. doi: 10.1159/000539354. Online ahead of print. Acta Haematol. 2024. PMID: 38781944
Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.
Henig I, Isenberg J, Yehudai-Ofir D, Leiba R, Ringelstein-Harlev S, Ram R, Avni B, Amit O, Grisariu S, Azoulay T, Slouzkey I, Zuckerman T. Henig I, et al. Among authors: ringelstein harlev s. Vaccines (Basel). 2023 Mar 31;11(4):775. doi: 10.3390/vaccines11040775. Vaccines (Basel). 2023. PMID: 37112688 Free PMC article.
Response rates of extra-nodal diffuse large B cell lymphoma to anti-CD19-CAR T cells: A real word retrospective multicenter study.
Beyar Katz O, Perry C, Grisariu-Greenzaid S, Yehudai-Ofir D, Luttwak E, Avni B, Zuckerman T, Sdayoor I, Stepensky P, Ringelstein-Harlev S, Bar-On Y, Libster D, Sharvit L, Amit O, Greenbaum U, Gold R, Herishanu Y, Benyamini N, Avivi I, Ram R. Beyar Katz O, et al. Among authors: ringelstein harlev s. Eur J Haematol. 2023 Jul;111(1):63-71. doi: 10.1111/ejh.13968. Epub 2023 Apr 10. Eur J Haematol. 2023. PMID: 36964939
Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.
Azoulay T, Slouzky I, Karmona M, Filatov M, Hayun M, Ofran Y, Sarig G, Ringelstein-Harlev S. Azoulay T, et al. Among authors: ringelstein harlev s. Cancer Immunol Immunother. 2023 Mar;72(3):707-718. doi: 10.1007/s00262-022-03284-4. Epub 2022 Sep 1. Cancer Immunol Immunother. 2023. PMID: 36048214 Free PMC article.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Avivi I, Perry C, Segman Y, Amit O, Bar-On Y, Katz OB, Gold R, Ribakovsky E, Avigdor A, Vainstein V, Goldschmidt N, Ringelstein-Harlev S, Horowitz NA, Gutwein O, Gurion R, Itchaki G, Abadi U, Nemets A, Sofer O, Vezker M, Tadmor T, Dally N, Filanovsky K, Leiba M, Sarid N, Benyamini N, Luttwak E, Herishanu Y, Ram R. Avivi I, et al. Among authors: ringelstein harlev s. Ann Hematol. 2022 Apr;101(4):755-762. doi: 10.1007/s00277-021-04749-9. Epub 2022 Jan 27. Ann Hematol. 2022. PMID: 35083525
19 results